Scarica l'app Stockscreener
15.03
2.71%
0.3949
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Olema Pharmaceuticals (OLMA) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Olema Pharmaceuticals seeks senior director to drive breast cancer marketing strategy - Traders Union
Five new Olema hires receive stock options at $14.32 a share - Stock Titan
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Olema Adds Deal Veteran Prakash Raman To Guide Oncology Partnerships - Sahm
Olema Pharmaceuticals, Inc. Announces New Lease Agreement and Provides Company Information – Form 8-K Filing - Minichart
Jennison Associates LLC Takes Position in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Pictet Asset Management Holding SA Trims Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals Signs New Headquarters Lease at Oyster Point - TipRanks
Olema Pharmaceuticals (NASDAQ: OLMA) inks 7-year HQ lease with $18.5M base rent - Stock Titan
OLMA Forecast, Price Target & Analyst Ratings | OLEMA PHARMACEUTICALS INC (NASDAQ:OLMA) - ChartMill
Olema Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash - Moomoo
Olema (NASDAQ: OLMA) director granted 27,061 stock options - Stock Titan
Olema Pharmaceuticals Adds Veteran Director to Support Growth - TipRanks
Olema Pharmaceuticals | 3: Initial statement of beneficial ownership of securities- Raman Prakash - Moomoo
New Olema (OLMA) director files initial insider ownership report - Stock Titan
[ARS] Olema Pharmaceuticals, Inc. SEC Filing - Stock Titan
Executive pay and board seats on ballot at Olema (NASDAQ: OLMA) 2026 meeting - Stock Titan
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event - Stock Titan
Olema Pharmaceuticals appoints Prakash Raman to board By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals appoints Prakash Raman to board - Investing.com
Prakash Raman named to Olema Pharmaceuticals board - Traders Union
Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors - Caledonian Record
Olema Pharmaceuticals (OLMA) loses 33.4% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Wall Street Zen Upgrades Olema Pharmaceuticals (NASDAQ:OLMA) to "Sell" - MarketBeat
Olema Pharmaceuticals seeks lead senior medical writer to strengthen oncology portfolio - Traders Union
OLMA (Olema Pharmaceuticals Inc.) posts narrow Q4 2025 EPS beat, sending shares up two percent in daily trading.Consensus Forecast - Cổng thông tin điện tử tỉnh Tây Ninh
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Olema Pharmaceuticals (OLMA) to Showcase Phase 1 Study Results a - GuruFocus
Olema brings first human OP-3136 cancer trial results to ASCO - Stock Titan
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting - marketscreener.com
Jim Cramer on Olema Pharmaceuticals: "Too risky for me" - MSN
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - MSN
Olema Pharmaceuticals expands workforce to drive oncology innovation - Traders Union
Can Olema Pharmaceuticals (OLMA) stock keep rising today (Slight Gain) 2026-04-20Community Watchlist - Cổng thông tin điện tử tỉnh Lào Cai
Piper Sandler Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Olema Pharmaceuticals (OLMA) Is Up 5.6% After Preclinical Data Highlight Deeper ER Blockade Potential - Sahm
A Look At Olema Pharmaceuticals (OLMA) Valuation After New Preclinical Breast Cancer Data - Sahm
Olema Pharmaceuticals (NASDAQ:OLMA) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting - Sahm
Olema Pharmaceuticals (OLMA) Stock: Why It Could Break Down (Smart Money Flows) 2026-04-18 - Cổng thông tin điện tử tỉnh Lào Cai
Olema Pharmaceuticals (OLMA) Unveils New Data on Palazestrant - GuruFocus
Olema Pharmaceuticals unveils new preclinical data ahead of AACR2026 presentation - Traders Union
Olema Pharmaceuticals, Inc. (OLMA) Stock Report: Exploring a Potential 160% Upside in the Biotech Sector - DirectorsTalk Interviews
Early development of Olema and Aurigene’s OP-3136 for breast cancer - BioWorld News
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat
Rate Cut: Is Olema Pharmaceuticals Inc forming bullish engulfing patterns2026 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):